Leave us a review in the app store!

Episodes

Feb. 22, 2024

E44: Chris Prestigiacomo of SWIB ($140B AUM) on What Pensions Look fo…

Chris Prestigiacomo, Portfolio Manager at the State of Wisconsin Investment Board (SWIB) sits down with David Weisburd and Erik Torenberg to discuss his journey, the role of private debt in venture portfolio management, and the Wisconsin Investment Board's asset allocation …

Episode page
Feb. 20, 2024

E43: Sasha Pieterse (Alison) of Pretty Little Liars Reveals Her New V…

Sasha Pieterse of Pretty Little Liars and now Co-Founder and CEO of Hippie Water, sits down with David Weisburd to discuss her journey from child actor to entrepreneur, her experiences working with renowned actors, and her new venture.

Episode page
Feb. 15, 2024

E42: 6 Hard Questions You Should Ask LPs When Raising Your Venture Ca…

Katie Riester, Managing Director at Felicis sits down with David Weisburd to discuss venture capital fund strategies, building relationships with GPs, and the math behind venture capital.

Episode page
Feb. 13, 2024

E41: How Everyday Investors Can Access Blackstone, Apollo, and KKR?

Michael Sidgmore of Broadhaven sits down with David Weisburd to talk about the growth of the wealth channel and its link to private equity.

Episode page
Feb. 8, 2024

E40: Dave McClure on Delivering a 40x & 60x fund and Founding 500 Sta…

Dave McClure sits down with David Weisburd to discuss his journey into venture capital, including luck, his investment strategy, and the challenges he faced breaking into the industry.

Episode page
Feb. 6, 2024

E39: Guy Perelmuter on Generating Alpha in Deeptech

Guy Perelmuter of GRIDS Capital sits down with David Weisburd to discuss his investment strategy, the unique portfolio construction of deep tech companies, and the potential of DeepTech.

Episode page
Feb. 1, 2024

E38: Carrie Thome & Grady Buchanan of NVNG on How to Raise Capital fr…

Carrie Thome and Grady Buchanan of NVNG sit down with David capital to talk about the importance of startups, and portfolio construction.

Episode page
Jan. 30, 2024

E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively W…

Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach.

Episode page
Jan. 26, 2024

E36: Masterclass on Portfolio Construction with Anubhav Srivastava, C…

Anubhav Srivastava, CEO of Tactyc, sits down with David Weisburd to discuss iterative portfolio construction, portfolio size impact, fund recycling and check size, reserve strategies, and follow-on investments.

Episode page
Jan. 23, 2024

E35: Ben Gallagher of Cannonball on "Value per Dollar Invested" and H…

Ben Gallacher sits down with David Weisburd to discuss venture capital, his journey as an LP, and the challenges emerging managers face.

Episode page
Jan. 18, 2024

E34: Aakar Vachhani Fairview on What The Top 1% of GPs Share in Common

Aakar Vachhani sits down with David Weisburd to discuss the role of data in venture capital, Fairview's unique structure, and their co-investment program.

Episode page
Jan. 16, 2024

E33: Charmel Maynard, CIO of University of Miami on Building a Ventur…

Charmel Maynard, CIO of University of Miami, sits down with David Weisburd to discuss asset allocation, diversification strategies, and the process of assessing venture funds.

Episode page
Jan. 11, 2024

E32: Ashby Monk, Stanford Professor on How to Become a Billionaire in…

Ashby Monk, Executive and Research Director at Stanford sits down with David Weisburd to discuss the role and operation of asset owners like pension funds, endowments, and more. They delve into compensation in these fields, the state of pension funds …

Episode page
Jan. 9, 2024

E31: David Friedberg on How To Build a Billion Dollar Startup

David Friedberg sits down with David Weisburd to discuss the role of concentrated capital, venture capital's future, and the impact of capital saturation. Friedberg shares his experience joining Ohalo, the evolution of investment strategy, and the transition from VC to …

Episode page
Jan. 4, 2024

E30: Alan Feld, Co-Founder of Vintage Investment Partners on How to H…

Alan Feld sits down with David Weisburd to talk about his experience founding Vintage, the significance of product-market fit in VC, and how Vintage has thrived over two decades. They discuss the impact of personal history on investment decisions, building …

Episode page
Jan. 1, 2024

E29: Lo Toney of Plexo Capital on How He Raised LP Capital from Googl…

David Weisburd interviews Lo Toney about his transition from angel investor to fund manager, his role at Plexo Capital, and his approach to working with founders. They discuss the importance of patience in early-stage investments, the diligence process for managers, …

Episode page
Dec. 14, 2023

E28: Roland Reynold of Industry Ventures on Investing $7 Billion into…

Roland Reynolds, Senior Managing Director at Industry Ventures, sits down with David Weisburd to discuss being one of the first investors in emerging managers and how he uses secondaries to drive alpha.

Episode page
Dec. 12, 2023

E27: Fernando Pontaza of Invariantes on Why 25% IRR is the Gold Stand…

Fernando Pontaza, Co-Founder of Invariantes sits down with David Weisburd to discuss setting up the first Guatemalan Venture Capital Fund and why he targets a 25% IRR.

Episode page
Dec. 8, 2023

E26: Winter Mead of Coolwater on Building the YC for GPs

Winter Mead, Founder and CEO of Coolwater Capital sits down with David Weisburd to discuss the importance of emerging managers and how Coolwater Capital is building the YC for GPs.

Episode page
Dec. 6, 2023

E25: Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV

Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV.

Episode page
Nov. 30, 2023

E24: Joshua Berkowitz of Berkocorp on Why LP’s Should Care about IRR …

Joshua Berkowitz of Berkocorp, sits down with David Weisburd to discuss investing in venture capital as a family office and why all investors should care about IRR (and not TVPI).

Episode page
Nov. 28, 2023

E23: How Israel’s Largest Hospital Delivers Care to Palestinians thro…

Brian Abrahams, CEO of American Friends of Sheba Medical Center, sits down with David Weisburd to discuss its “Peace through Health Initiative” and how the hospital has been helping Israeli and Palestinian citizens during the current conflict.

Episode page
Nov. 21, 2023

E22: Alex Edelson of Slipstream on The 4 Sources of Alpha for Emergin…

Alex Edelson of Slipstream Investors, sits down with David Weisburd and Erik Torenberg to discuss the four sources of alpha for emerging managers (Sourcing, Picking, Winning, and Value-Add).

Episode page
Nov. 16, 2023

E21: Jake Paul and Joey Levy of Betr on How to Build a $100 Billion C…

Jake Paul and Joey Levy, co-founder of Betr, sit down with David Weisburd to discuss the sports betting industry and how to build a $100 billion company.

Episode page